China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project
Recruiting · NCT05316805 · Observational (researchers observe without assigning treatment) · Lead sponsor: Peking University First Hospital
View the official record on ClinicalTrials.gov →What this trial is about
In order to further improve the diagnosis and treatment level of type 2 inflammatory skin diseases, the National Clinical Center for Skin and Immune Diseases established a standardized diagnosis and treatment center for type 2 inflammatory skin diseases to systematically and effectively understand the current treatment status of patients with type 2 inflammatory skin diseases, as well as the efficacy and safety of various treatment methods during practices, so as to further improve the diagnosis and treatment level of type 2 inflammatory skin diseases and help patients with type 2 inflammatory skin diseases.
Who can take part
Inclusion criteria
- Patients from the medical units that has passed the data review of the National Clinical Center for Skin and Immune Diseases (see the study sites for data collection for details);
- patients diagnosed with type 2 inflammatory skin diseases (dermatitis/eczema, urticaria, pemphigoid, prurigo nodularis).
Exclusion criteria
- patients who fail to provide informed consent form;
- patients who cannot complete the questionnaire independently or under the guidance of investigators
Where it is running
1 location listed.
- Peking University First Hospital - Beijing, China